EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

TMAO at the Crossroads of the Gut–Brain Axis: Emerging Mechanisms Linking Microbiota-Derived Metabolites to Neuroinflammation and Cognitive Dysfunction

Aseel Y Altahrawi iD, Fatimah Sofi, Zara Kanjwal, Zahoor A Shah iD

Cells · 2026

DOI: 10.3390/cells15201845 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Aseel Y Altahrawi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, OH 43614…. Hauptthemen laut MEDLINE: Methylamines, Neuroinflammatory Diseases, Gastrointestinal Microbiome, Cognitive Dysfunction. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurologic Diseases and Stroke, Jordan University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trimethylamine-N-oxide (TMAO) is a gut microbiota-derived metabolite produced through the hepatic oxidation of trimethylamine. Although TMAO has been widely investigated as a therapeutic target in multiple cardiovascular and metabolic diseases, growing evidence suggests it may play a critical role in the neuroinflammation and cognitive dysfunction associated with the gut–brain axis. This narrative review summarizes the current literature to synthesize evidence on the mechanisms linking TMAO with neurological disorders; it discusses potential mechanisms contributing to this association, with particular focus on neuroinflammation, oxidative stress, and activation of inflammatory pathways. Overall, this review also suggests the potential use of TMAO and its precursors as therapeutic targets for multiple neurodegenerative disorders. However, it emphasizes the need for conducting large, adequately powered randomized clinical studies to determine its therapeutic relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylaminesNeuroinflammatory DiseasesGastrointestinal MicrobiomeCognitive DysfunctionBrainBrain-Gut AxisHumansAnimalsOxidative StressInflammation

Stichwörter der Autor:innen

TMAOgut–brain axisneurological diseasestherapeutic strategies

Substanzen

Methylaminestrimethyloxamine

Autor:innen und Institutionen

  • Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, OH 43614, USA.
  • Department of Medicinal and Biological Chemistry, College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, OH 43614, USA.

ORCID-Profile: Aseel Y Altahrawi, Zahoor A Shah

Förderung

  • NINDS NIH HHS
  • National Institute of Neurologic Diseases and Stroke
  • Jordan University of Science and Technology

Zitieren

APA

Altahrawi, A. Y., Sofi, F., Kanjwal, Z., & Shah, Z. A. (2026). TMAO at the Crossroads of the Gut–Brain Axis: Emerging Mechanisms Linking Microbiota-Derived Metabolites to Neuroinflammation and Cognitive Dysfunction. Cells. https://doi.org/10.3390/cells15201845

Vancouver

Altahrawi AY, Sofi F, Kanjwal Z, Shah ZA. TMAO at the Crossroads of the Gut–Brain Axis: Emerging Mechanisms Linking Microbiota-Derived Metabolites to Neuroinflammation and Cognitive Dysfunction. Cells. 2026. doi:10.3390/cells15201845

BibTeX
@article{Altahrawi2026,
  author = {Altahrawi, Aseel Y and Sofi, Fatimah and Kanjwal, Zara and Shah, Zahoor A},
  title = {TMAO at the Crossroads of the Gut–Brain Axis: Emerging Mechanisms Linking Microbiota-Derived Metabolites to Neuroinflammation and Cognitive Dysfunction},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15201845}
}
Kostenlos starten →